pyroptosis inducer lps s7850 nigericin (Selleck Chemicals)
Structured Review

Pyroptosis Inducer Lps S7850 Nigericin, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 44 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nigericin/Nigericin+sodium+salt/pmc12377955-32-9-19
Average 95 stars, based on 44 article reviews
Images
1) Product Images from "GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC"
Article Title: GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC
Journal: Mediators of Inflammation
doi: 10.1155/mi/5576056
Figure Legend Snippet: GPR34 deletion promotes ferroptosis of ATC cells. (A, B) The CCK8 assay was used to determine the viability of BHT101 (A) and 8305C (B) cells with GPR34 knockdown after addition of the apoptosis inducer VCR, ferroptosis inducer RSL-3, autophagy inducer rapamycin, or pyroptosis inducer LPS + nigericin. (C, D) Representative images were presented of BHT101 (C) and 8305C cells (D) with GPR34 deletion treated with RSL-3. (E, F) The CCK8 assay was used to assess the responses of BHT101 (E) and 8305C cells (F) with GPR34 silencing to RSL-3 ± Fer-1. (G) IHC test on xenograft tumors was performed to identify the correlation between GPR34 and 4-HNE expression. (H, I) Lipid ROS (H) and GSH (I) levels in GPR34 deletion ATC cells. Ns, nonsignificant. p > 0.05, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
Techniques Used: CCK-8 Assay, Knockdown, Expressing
Related Articles
other:Article Title: Phase separation drives NLRP3 inflammasome activation independently of Golgi localization Article Snippet: In Vitro:Article Title: NRG1 Suppresses NLRP3 Inflammasome Activation and Endothelial-Mesenchymal Transition in Cerebral Ischemia-Reperfusion Injury: Association with the AKT/NF-κB Pathway Article Snippet: .. In vitro, ischemia was simulated using the OGD/R model. MCC950 (S7809; Selleck, USA), a selective NLRP3 inflammasome inhibitor, and Recombinant:Article Title: Cerebral organoid exosomes reversed behavioral deficits by repressing NLRP3 mediated neuroinflammation in stress models Article Snippet: .. 441 442 STAR★Methods 443 Key resources table 444 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Jo urn al Pr e-p roo f 22 CD9 CST Cat# D8O1A CD63 Abcam Cat# ab134045 TSG101 Santa Cruz Cat# sc-7964 Arg-1 Boster Cat# BM4000 CD206 Abcam Cat# ab64693 iNOS Boster Cat# BA0362 GFAP Abcam Cat# ab7260 C3 Thermo Cat# PA5-21349 IBA-1 Protein tech; Wako Cat# 10904-1-AP; Cat# 019-19741 NLPR3 Protein tech Cat# 30109-1-AP Casp-1 Sigma Cat# AB1871 IL-1β ABclonal Cat# A16288 BDNF Abcam Cat# ab108319 TrkB R&D Cat# AF1494 SYN1 SYSY Cat# 106011 PSD95 SYSY Cat# 124003 SOX2 R&D Cat# AF2018-SP TBR2 Abcam Cat# ab216870 CTIP2 Abcam Cat# ab18465 PAX6 Abcam Cat# ab195045 MAP2 Sigma Cat# M4403 TUJ1 Abcam Cat# ab78078 FZD9 SAB Cat# 31503 GAPDH Protein tech Cat# 60004-1-Ig β-actin Santa Cruz Cat# sc-8432 DAPI Beyotime Cat# C1002 Chemicals, peptides, and recombinant proteins Nigericin Selleck Cat# Mass Spectrometry:Article Title: Cerebral organoid exosomes reversed behavioral deficits by repressing NLRP3 mediated neuroinflammation in stress models Article Snippet: .. 441 442 STAR★Methods 443 Key resources table 444 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Jo urn al Pr e-p roo f 22 CD9 CST Cat# D8O1A CD63 Abcam Cat# ab134045 TSG101 Santa Cruz Cat# sc-7964 Arg-1 Boster Cat# BM4000 CD206 Abcam Cat# ab64693 iNOS Boster Cat# BA0362 GFAP Abcam Cat# ab7260 C3 Thermo Cat# PA5-21349 IBA-1 Protein tech; Wako Cat# 10904-1-AP; Cat# 019-19741 NLPR3 Protein tech Cat# 30109-1-AP Casp-1 Sigma Cat# AB1871 IL-1β ABclonal Cat# A16288 BDNF Abcam Cat# ab108319 TrkB R&D Cat# AF1494 SYN1 SYSY Cat# 106011 PSD95 SYSY Cat# 124003 SOX2 R&D Cat# AF2018-SP TBR2 Abcam Cat# ab216870 CTIP2 Abcam Cat# ab18465 PAX6 Abcam Cat# ab195045 MAP2 Sigma Cat# M4403 TUJ1 Abcam Cat# ab78078 FZD9 SAB Cat# 31503 GAPDH Protein tech Cat# 60004-1-Ig β-actin Santa Cruz Cat# sc-8432 DAPI Beyotime Cat# C1002 Chemicals, peptides, and recombinant proteins Nigericin Selleck Cat# Software:Article Title: Cerebral organoid exosomes reversed behavioral deficits by repressing NLRP3 mediated neuroinflammation in stress models Article Snippet: .. 441 442 STAR★Methods 443 Key resources table 444 REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Jo urn al Pr e-p roo f 22 CD9 CST Cat# D8O1A CD63 Abcam Cat# ab134045 TSG101 Santa Cruz Cat# sc-7964 Arg-1 Boster Cat# BM4000 CD206 Abcam Cat# ab64693 iNOS Boster Cat# BA0362 GFAP Abcam Cat# ab7260 C3 Thermo Cat# PA5-21349 IBA-1 Protein tech; Wako Cat# 10904-1-AP; Cat# 019-19741 NLPR3 Protein tech Cat# 30109-1-AP Casp-1 Sigma Cat# AB1871 IL-1β ABclonal Cat# A16288 BDNF Abcam Cat# ab108319 TrkB R&D Cat# AF1494 SYN1 SYSY Cat# 106011 PSD95 SYSY Cat# 124003 SOX2 R&D Cat# AF2018-SP TBR2 Abcam Cat# ab216870 CTIP2 Abcam Cat# ab18465 PAX6 Abcam Cat# ab195045 MAP2 Sigma Cat# M4403 TUJ1 Abcam Cat# ab78078 FZD9 SAB Cat# 31503 GAPDH Protein tech Cat# 60004-1-Ig β-actin Santa Cruz Cat# sc-8432 DAPI Beyotime Cat# C1002 Chemicals, peptides, and recombinant proteins Nigericin Selleck Cat# |
![Identification of a benzo[ d ]imidazo[1,2‐ a ]imidazole scaffold with selective anti‐ferroptotic activity. (a) Protective effects of a focused nitrogen‐containing heterocyclic compound library (10 µ m , 24 h) against RSL3‐induced ferroptosis (0.2 µ m , 24 h) in HT‐1080 cells, as determined by the CCK‐8 assay. The cell viability of the RSL3‐treated group is indicated by the red dashed line. (b) Chemical structures of representative active and inactive compounds sharing the benzo[ d ]imidazo[1,2‐ a ]imidazole core scaffold. (c) Chemical structures and effects against RSL3‐induced ferroptosis of scaffold‐modified derivatives. Inhibitory activity of selected compounds against ferroptosis induced by 10 µ m Erastin (d) and 1 µ m FIN56 (e) in HT‐1080 cells. 1 µ m Fer‐1 was used as a positive control. (f) Inhibitory activity of selected compounds against apoptosis induced by 1 µM Staurosporine (STS) in HT‐1080 cells. 100 µ m Z‐VAD‐FMK was used as a positive control. (g) Inhibitory activity of selected compounds against necrosis induced by 3 mM H 2 O 2 in HT‐1080 cells. (h) Inhibitory activity of selected compounds against cuproptosis induced by Elesclomol‐Cu 2+ (1 µ m , 1:1) in HT‐1080 cells. 10 µ m Ammonium tetrathiomolybdate (TTM) was used as a positive control. (i) Inhibitory activity of selected compounds against parthanatos induced by 300 µ m methyl methanesulfonate (MMS) in HT‐1080 cells. (j) Inhibitory activity of selected compounds against necroptosis induced by TNF‐α/SM‐164/Z‐VAD‐FMK in L‐929 cells. 30 µ m Necrostatin‐1 (Nec‐1) was used as a positive control. (k) Inhibitory activity of selected compounds against pyroptosis induced by LPS (500 ng/mL, 4 <t>h)/Nigericin</t> (10 µ m , 2 h) in BMDM cells. 30 µ m Necrosulfonamide (NSA) was used as a positive control. Data in panels (d–k) are presented as mean ± SD ( n = 3). ### p < 0.001 vs. the Control group; *** p < 0.001 vs. the Model group.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1665/pmc13771665/pmc13771665__ADVS-9999-e78710-g009.jpg)


